Prompt

What are the best free API suppliers to compare for supply risk and pricing in generic pharma sourcing?

Pharmaceuticals · Generic Pharma / Generic pharma1 observationLast seen Aug 15, 2026

Latest observation

Aug 15, 2026 · OpenAI APIWeb search: off

If you want to compare supply risk and pricing for generic pharma sourcing using free APIs, the reality is that there are very few truly “free, pharma-specific procurement APIs” with complete pricing and supplier-risk data. In practice, the best approach is to combine:

  1. Free trade / regulatory / customs / sanctions / company data APIs
  2. Free market / price-discovery APIs where available
  3. Open datasets and public registries
  4. A little web scraping / manual validation for actual commercial quotes

Here are the best free API suppliers/data sources to compare, grouped by use case.


1) Supply risk: best free APIs/data sources

A. OpenCorporates API

  • Use for: supplier identity, corporate structure, ownership, jurisdiction, directors
  • Why it helps: Great for basic supplier due diligence and mapping parent/subsidiary exposure
  • Free tier: Yes, with limited calls
  • Good for: spotting concentration risk, shell entities, and geographic exposure

B. GLEIF / LEI API

  • Use for: legal entity verification and global corporate identifiers
  • Why it helps: Helps verify whether a supplier is a real operating entity and map related companies
  • Free tier: Yes
  • Good for: entity resolution across borders

C. OFAC / EU sanctions / UK sanctions open data

  • Use for: sanctions screening
  • Why it helps: immediate compliance risk flagging
  • Free tier: Yes
  • Good for: supplier and beneficial owner screening

D. OpenSanctions

  • Use for: sanctions, PEP, adverse media-style entity screening
  • Why it helps: broader risk screening than sanctions lists alone
  • Free tier: Limited / open data availability
  • Good for: early-stage supplier risk checks

E. FDA APIs / open FDA data

  • Use for: US drug manufacturing, recalls, shortages, inspection-related information
  • Why it helps: relevant for API and finished dose supply risk
  • Free tier: Yes
  • Good for: manufacturing quality and shortage context

F. EMA / EudraGMDP public data

  • Use for: EU manufacturing authorizations, GMP-related visibility
  • Why it helps: verifies whether manufacturing sites are authorized/known
  • Free tier: Public access, often not a modern API in every case, but useful data access
  • Good for: site qualification and compliance checks

G. WHO / national shortage databases

  • Use for: medicine shortages and public health supply constraints
  • Why it helps: one of the best indicators of systemic supply risk
  • Free tier: Yes, depending on country/source
  • Good for: demand/supply imbalance detection

H. UN Comtrade API

  • Use for: import/export flows and trade concentration
  • Why it helps: helps identify sourcing country dependence and trade disruption exposure
  • Free tier: Yes, limited but useful
  • Good for: country-level supply chain risk

I. World Bank / OECD / IMF APIs

  • Use for: macroeconomic and country-risk indicators
  • Why it helps: useful for ranking sourcing geographies on stability, logistics, currency, and business environment
  • Free tier: Yes
  • Good for: country risk enrichment

J. OpenStreetMap / geocoding APIs

  • Use for: location verification
  • Why it helps: helps validate plant locations and logistics route exposure
  • Free tier: Yes, with limits
  • Good for: supply network mapping

2) Pricing: best free APIs/data sources

True API-based generic pharma pricing is hard to get for free because real procurement prices are often private. The best free sources are:

A. National drug price/reference databases

Depending on the market, these can be excellent:

  • US: CMS / Medicaid NADAC / ASP-related public data
  • UK: NHS Drug Tariff / NHSBSA datasets
  • India: NPPA / price control data
  • Australia: PBS
  • EU countries: various public reimbursement/price datasets

Why they help: they provide benchmark pricing, even if not your exact negotiated price.

B. OpenFDA / FDA Orange Book

  • Use for: identifying generic competitors and market structure
  • Why it helps: more competition often correlates with lower prices and better resilience
  • Free tier: Yes

C. DailyMed

  • Use for: product labeling and NDC mapping
  • Why it helps: supports price matching and SKU normalization
  • Free tier: Yes

D. NIH / PubChem / ChEMBL

  • Use for: API and molecule-level identification
  • Why it helps: helps map equivalent compounds across suppliers and markets
  • Free tier: Yes

E. Open contracting / tender datasets

  • Use for: government procurement prices
  • Why it helps: often the closest thing to real transaction prices for generics
  • Free tier: Yes, if the jurisdiction publishes them
  • Good for: benchmark and negotiation intelligence

F. Pharmexcil / customs / trade datasets

  • Use for: indicative import values and trends
  • Why it helps: can support landed-cost estimates by origin
  • Free tier: varies

3) Best “free API supplier” shortlist to compare first

If your goal is to build a practical sourcing-risk dashboard, start with these:

Core risk stack

  1. OpenCorporates
  2. GLEIF LEI API
  3. Sanctions lists (OFAC/EU/UK)
  4. UN Comtrade
  5. FDA / openFDA
  6. WHO or national shortage data
  7. World Bank / OECD country risk data

Core pricing stack

  1. CMS/NADAC or equivalent national price files
  2. Government tender/procurement datasets
  3. NHS/National reimbursement datasets
  4. Orange Book / DailyMed
  5. Trade/customs value datasets

4) What to compare when evaluating these APIs

Use these criteria:

  • Coverage
    • Countries, suppliers, molecules, sites, and SKUs
  • Freshness
    • Update frequency
  • Granularity
    • Company vs site vs product vs batch
  • Identity resolution
    • Can it map supplier names cleanly?
  • Bias / completeness
    • Are small manufacturers missing?
  • Cost and rate limits
    • Free tier usability
  • Licensing
    • Can you store and reuse the data?
  • Integration quality
    • REST, CSV, bulk download, documentation

5) Practical recommendation

For generic pharma sourcing, the most useful free combination is:

  • Supplier due diligence: OpenCorporates + GLEIF + sanctions lists
  • Quality/supply risk: FDA/openFDA + EMA/EudraGMDP + shortage databases
  • Trade exposure: UN Comtrade + World Bank country indicators
  • Price benchmarks: national reference pricing + tender datasets + reimbursement files

6) Important caveat

If you need:

  • real-time supplier quotes
  • actual negotiated B2B prices
  • manufacturer capacity data
  • batch-level quality metrics

…those are usually not available for free via clean APIs and often require:

  • paid data vendors,
  • direct supplier portals,
  • or custom scraping/ETL.

If you want, I can also give you:

  1. a ranked list of specific APIs by country/region, or
  2. a comparison table with fields, limits, and use cases for building a sourcing-risk model.

Observation history

Unlock observation history

Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.